Affidea Polska
Affidea Polska operates 43 diagnostic imaging and oncology facilities across 31 Polish cities, performing approximately 500,000 examinations annually and serving both NFZ-reimbursed and private-pay patients, including general diagnostics, cancer care, and memory disorder services.
- Company typePrivate
- Founded2000
- HeadquartersWarsaw, Poland
- Headcount101–250
- GTM typeB2C
- OfferingServices
What Affidea Polska does
Affidea Polska is a private Polish healthcare operator providing diagnostic imaging and oncological treatment services through a network of 43 medical facilities across 31 cities. The company performs approximately 500,000 examinations per year, accounting for an estimated 10% of MRI examinations and 20% of PET/CT examinations in Poland, and operates 6 radiotherapy centers including International Oncology Centers in Koszalin and Poznań and Affidea NU-MED facilities. Service offerings span MRI, CT, PET/CT (including PET/CT-PSMA for prostate cancer), scintigraphy, ultrasound, X-ray, virtual colonoscopy, and oncology care including radiotherapy, brachytherapy, teletherapy, and combined hyperthermia treatment.
The technology foundation rests on advanced diagnostic imaging equipment paired with specialized software and examination protocols, including a EuroSafe Imaging-recognized Dose Excellence program for radiation safety. Adjacent services include one-day surgery (Affidea Lublin), clinical trials, and a teleradiology service. The company operates dedicated patient and physician portals for appointment scheduling, results retrieval, and referring physician workflows. The group lives within the broader Affidea Europe network (14 countries, 420+ facilities, 20M examinations/year), and Polish operations are conducted through two legal entities: Affidea Sp. z o.o. (diagnostic imaging) and Affidea Onkoterapia Sp. z o.o. (radiotherapy).
Affidea Polska's revenue model is a hybrid of publicly reimbursed and private-pay diagnostic and treatment services. Reimbursement is contracted through the Polish National Health Fund (NFZ) for insured patients, complemented by private examination pricing with per-test unit economics and location-specific downloadable price lists. Customer segments span the general patient population, cancer patients (oncology), referring physicians, and neurological patients (Affidea neuraCare memory disorders). Marketing and distribution are primarily through direct facility access, with phone-based and online appointment booking, physician referral networks, and NFZ contractual channels.
Affidea Polska firmographics
Firmographics- Name
- Affidea Polska
- Legal name
- Affidea Sp. z o.o.
- Website
- https://affidea.pl
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Affidea Polska operates 43 diagnostic imaging and oncology facilities across 31 Polish cities, performing approximately 500,000 examinations annually and serving both NFZ-reimbursed and private-pay patients, including general diagnostics, cancer care, and memory disorder services.
- Ownership category
- akta.pro rank
Affidea Polska industry classification
Industry- Product category
- Diagnostic Imaging and Oncology Services
- NAICS
- Diagnostic Imaging Centers (621512), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Offices of Physicians (62111)
- SIC
- Services-Medical Laboratories (8071), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Health Services (8000)
- akta.pro primary industry
- Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)
- akta.pro secondary industries
- Oncology & Cancer Specialty Hospitals (HLAFAHAC), Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound) (HLAFAKAA), Medical Oncology (HLAKAFAB)
Keywords
Where Affidea Polska is headquartered
LocationHeadquarters
- HQ city
- Warsaw
- HQ country
- Poland
- HQ region
- Europe
Offices34 records
Markets served
Affidea Polska business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Diagnostic Imaging Services: Medical diagnostic imaging services including MRI, CT, PET/CT, scintigraphy, ultrasound, X-ray, and virtual colonoscopy. Revenue generated through NFZ reimbursement and private patient payments.
- Oncological Treatment Services: Radiotherapy, teleradiotherapy, brachytherapy, and combined treatment including consultations, imaging diagnostics, and radiation therapy for cancer patients. Provided through Affidea Onkoterapia Sp. z o.o.
- Hospital and Day Surgery Services: Affidea Lublin operates as a hospital providing one-day surgery services
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Pay-as-you-go | NFZ-funded services |
| Unit Pricing | Pay-as-you-go | Private examination pricing |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels6 records
Affidea Polska product offering
Product offeringCore offering
Affidea Polska operates a national network of 43 diagnostic imaging and oncology treatment facilities across 31 Polish cities, employing 500 specialists to deliver MRI, CT, PET/CT, scintigraphy, ultrasound, X-ray, virtual colonoscopy, radiotherapy, brachytherapy, combined hyperthermia, oncology consultations, clinical trials, and teleradiology services. Offerings are paid via NFZ reimbursement, private insurance, or self-pay.
Product overview
Affidea Polska operates as a network of 43 medical facilities across 31 cities in Poland, offering diagnostic imaging and oncological treatment services. The company provides a unified platform of imaging services (MRI, CT, PET/CT, scintigraphy, ultrasound, X-ray, virtual colonoscopy) supported by specialized oncology treatment centers offering radiotherapy, brachytherapy, and combined therapies. Key facility brands include Affidea NU-MED (oncology centers), Międzynarodowe Centra Onkologii (International Oncology Centers in Koszalin and Poznań), and Affidea neuraCare (memory disorder center in Warsaw). The network also includes one-day surgery at Affidea Lublin, clinical trial services, and digital portals for patients and physicians. Services are delivered through NFZ (public health insurance) reimbursement and private pay models.
Differentiator
Problem solved
Functional benefit
Brands
- Affidea NU-MED: Oncology treatment centers providing radiotherapy, teletherapy, brachytherapy, and combined oncology treatment
- Affidea neuraCare
- Międzynarodowe Centra Onkologii Affidea
Products and services
- Diagnostic Imaging Services
Quantifiable outcome
- 1 in 10 MRI examinations in Poland performed at Affidea facilities
- +3 more outcomes
Companies that use Affidea Polska
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles3 records
Affidea Polska technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Affidea Polska partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core, supporting and strategic.
- National Health Fund (NFZ)coreNFZ (Narodowy Fundusz Zdrowia) is the Polish National Health Fund providing public health insurance. Affidea operates as a contracted provider offering diagnostic imaging and oncology services covered under the public healthcare system, enabling access to services for insured patients.
- Fundacja Affidea NU-MEDsupportingAffidea NU-MED Foundation supports charitable activities and patient assistance programs. The foundation enables community support and social responsibility initiatives for cancer patients and their families.
- KPO (Krajowy Plan Odbudowy) - National Recovery PlanstrategicKPO (National Recovery Plan) is a European Union funding mechanism for post-pandemic recovery. Affidea received KPO funding for oncology projects including modernization of accelerator facilities and linear accelerator replacement at the International Oncology Center in Koszalin, as well as comprehensive treatment planning system upgrades.
Scale indicators8 records
Recent moves6 records
Expansion highlights9 records
Affidea Polska competitors and assessment
Company assessmentBroad incumbents
- Synlab: Major European medical diagnostics and imaging provider. Comparable to Affidea Europe/Polska as a large incumbent in multi-country diagnostic imaging and laboratory services with NFZ-style public reimbursement exposure.
- Unilabs: European diagnostic services provider offering imaging and laboratory services across multiple countries. Comparable to Affidea Europe as a continental-scale incumbent in cross-border diagnostic imaging and lab operations.
- Affidea Group (Affidea Europe): Pan-European parent operating 420+ diagnostic imaging and oncology facilities across 14 countries. Comparable as the broader incumbent owner of Affidea Polska, providing capital, procurement, and clinical standards across the network.
Direct peers
- ALAB laboratoria: National network of medical laboratories offering diagnostic testing across Poland. Comparable to Affidea's diagnostic services arm on multi-site NFZ-contracted operations and broad geographic coverage.
- Diagnostyka S.A. One of the largest private diagnostic imaging and laboratory networks in Poland, operating MRI, CT, PET/CT, and lab services across multiple cities. Directly comparable to Affidea Polska in modality mix, NFZ contract reliance, and multi-site operating model.
- Synevo (Medicover): Polish diagnostic laboratory and imaging network operated within the Medicover group. Overlaps with Affidea on lab and imaging services delivered through multi-site centers under NFZ and private reimbursement.
- LUX MED (Bupa): Largest private healthcare provider in Poland, offering outpatient diagnostics, imaging, and specialty care. Overlaps with Affidea on advanced imaging and outpatient specialist services, with similar NFZ/private mix and large-city density.
- Medicover: Integrated private healthcare operator in Poland providing diagnostics, specialty clinics, and hospital services. Comparable to Affidea's multi-site outpatient and specialty footprint, including imaging and oncology-adjacent services.
Regional players
- Centrum Medyczne Damiana: Private healthcare network in Warsaw delivering outpatient diagnostics, imaging, and specialist consultations. Comparable to Affidea's Warsaw facilities on advanced imaging and specialist-led outpatient services.
- Swissmed Centrum Zdrowia: Private healthcare operator in northern Poland offering diagnostics, specialty clinics, and surgical services. Comparable to Affidea on multi-modality private outpatient services in overlapping Polish regions.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Affidea Polska social profiles
Digital presenceAffidea Polska financial estimates
Financial estimateRevenue estimate
Valuation estimate
Affidea Polska leadership team
Management profileNumber of profiles
Affidea Polska subsidiaries and ownership
Company hierarchySubsidiaries2 records
Affidea Polska funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Affidea Polska M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Affidea Polska
What does Affidea Polska do?
Affidea Polska operates a national network of 43 diagnostic imaging and oncology treatment facilities across 31 Polish cities, employing 500 specialists to deliver MRI, CT, PET/CT, scintigraphy, ultrasound, X-ray, virtual colonoscopy, radiotherapy, brachytherapy, combined hyperthermia, oncology consultations, clinical trials, and teleradiology services. Offerings are paid via NFZ reimbursement, private insurance, or self-pay.
Is Affidea Polska a public or private company?
Affidea Polska is a private company. It is classified as corporate owned and is currently operating.
When was Affidea Polska founded?
Affidea Polska was founded in 2000. It employs 101 to 250 people.
Where is Affidea Polska based?
Affidea Polska is headquartered in Warsaw, Poland, in the Europe region.
How does Affidea Polska make money?
Three revenue lines are on record. Diagnostic Imaging Services are the primary driver. The others are oncological Treatment Services and hospital and Day Surgery Services.
Who are Affidea Polska's main competitors?
Broad incumbents on record are Synlab, Unilabs and Affidea Group (Affidea Europe). Direct peers are ALAB laboratoria, Diagnostyka S.A., Synevo (Medicover), LUX MED (Bupa) and Medicover. Regional players are Centrum Medyczne Damiana and Swissmed Centrum Zdrowia.
Does Affidea Polska have an API?
No public API is recorded for Affidea Polska.
What industry is Affidea Polska in?
Affidea Polska's product category is Diagnostic Imaging and Oncology Services. Its primary akta.pro industry code is HLAFAKAB, Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology), with a secondary code of HLAFAHAC, Oncology & Cancer Specialty Hospitals. Its NAICS code is 621512 and its SIC code is 8071.